Precision Optics (POCI) vs Stereotaxis (STXS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Precision Optics (POCI) has outperformed Stereotaxis (STXS) over the past year, gaining 7.2% versus a loss of 67.1%. Over five years, POCI leads with a -29.3% price change compared with -81.3% for STXS. Stereotaxis is the larger company by market cap ($111.2 million vs $50.3 million), about 2.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | POCI | STXS |
|---|---|---|
| Share price | $4.58 | $1.11 |
| Market cap | $50.26M | $111.22M |
| 1-day change | -1.82% | 0.00% |
| YTD return | +11.34% | -51.74% |
| 1-year return | +7.24% | -67.06% |
| 5-year return | -29.32% | -81.28% |
| Forward P/E | 152.67 | — |
| EPS (TTM) | $-0.43 | $-0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.15 | $3.42 |
| 52-week low | $3.55 | $1.09 |
| Distance from 52-week high | -25.53% | -67.54% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +74.67% | +170.27% |
| Average volume | 51.88K | 808.41K |
| Shares outstanding | 10.97M | 100.20M |
| Employees | 108 | 131 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Stereotaxis is about 2.2 times larger than Precision Optics by market value ($111.22M vs $50.26M).
- POCI has outperformed STXS by 74.3 percentage points over the past year.
About Precision Optics
POCI stock →Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 108 employees
About Stereotaxis
STXS stock →Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 131 employees
POCI vs STXS FAQ
Which is bigger, Precision Optics or Stereotaxis?
Stereotaxis (STXS) is larger, with a market capitalization of $111.22M compared with $50.26M for Precision Optics (POCI).
Which stock has performed better over the past year, POCI or STXS?
POCI returned +7.24% over the past 12 months, compared with -67.06% for STXS (price return, excluding dividends). Past performance does not predict future results.
Are Precision Optics and Stereotaxis in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.